Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2018 September;43(3) > Minerva Endocrinologica 2018 September;43(3):367-76

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Endocrinologica 2018 September;43(3):367-76

DOI: 10.23736/S0391-1977.17.02617-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Thyroid dysfunction and non-alcoholic fatty liver disease

Zoe A. EFSTATHIADOU , Marina D. KITA, Stergios A. POLYZOS

Department of Endocrinology, Hippokration General Hospital, Thessaloniki, Greece


PDF


Thyroid hormones are crucial for hepatic lipid and glucose metabolism. Non-alcoholic fatty liver disease (NAFLD), a very common and potentially serious disease of modern society, shares common clinical features with hypothyroidism, such as obesity, insulin resistance and dyslipidemia. Furthermore, in certain studies, increased prevalence of hypothyroidism was observed in patients with NAFLD. However, whether there is a linear relationship between thyroid hormone levels, including values within or in proximity to the reference range and NAFLD incidence and severity remains a contradictory subject in the literature. On the other hand, attempts to treat NAFLD with thyromimetic drugs remain at an early stage. In this review, data derived from observational studies along with evidence on possible treatment with thyroid hormone analogues are presented.


KEY WORDS: Non-alcoholic fatty liver disease - Hypothyroidism - Thyroid diseases

inizio pagina